We all know that getting treatment for cancer, even for the most basic ones and the most necessary ones like chemotherapy costs a fortune. With that sad reality that the healthcare industry is facing today, chances are, if you get cancer either you will be buried in debt, or you will spend a lot of money treating the disease. Read more about Mikhail on Crunchbase.
The scary thing about cancer is that it is one of the deadliest diseases in the world and that goes for everyone, be it rich or poor. Cancer can kill even the richest of us. But, at least, for the rich, they will have more options, and even if they do succumb to the disease, they will have something to leave their family. But what about the poor?
This terrifying reality is why Mikhail Blagosklonny has spent his life researching cures or treatment for cancer that are both effective and affordable to everyone. This represents both his passion as one of the top oncologists in the world, and his philanthropic work.
Mikhail Blagosklonny’s work is known for his research on Rapamycin which is now considered a wonder drug, a term utilized by medicine to describe a drug that has multiple uses that are beneficial to our organism in treatments and therapies. Rapamycin helps in cancer treatment in two ways: immunosuppression and anti-proliferation.
Rapamycin has already been proven to prevent cancers cells from spreading to the other tissues or organs of the body. Is it already the approved primary drug for curing Lymphangioleiomyomatosis or LAM. Rapamycin’s immunosuppression properties is also a big help in organ transplant. View Mikhail’s profile on Google Scholar.
There are times when cancer has already spread so much in a patient’s organ that a transplant is required to save the patient. The problem is, the body’s immune system always responds to fight off foreign objects that it detects, and in most cases, the body’s immune system would try to ‘fight off’ an organ that doesn’t belong to the original body. And that is where Rapamycin comes into play. It suppresses that ‘organ rejection’ response of the immune system.
In the industry of medicine, the field that has specialized in cancer therapy would not be the same today without the work of Mikhail, as the wonder drug, which he has put extended hours studying and developing theories on how to use it in healthcare, has become an essential part of more than half of the treatments available worldwide.